Table 1.

Functional pathways showing a significant difference in expression in the stool microbiome between patients with inflammatory bowel disease and healthy controls.

KEGG Pathway	Definition	LDA Effect Size *	FDR Adjusted p-Value
Increased in IBD compared to the control
KO01100	Metabolic pathways	3.490	<0.001
KO00511	Other glycan degradation	3.062	<0.001
KO00520	Amino sugar and nucleotide sugar metabolism	3.047	<0.001
Decreased in IBD compared to the control
KO02010	ABC transporters	3.194	<0.001

FDR, false discovery rate; IBD, inflammatory bowel disease; KEGG, Kyoto Encyclopedia of Genes and Genomes; LDA, linear discriminant analysis. * Only taxa showing LDA effect size ≥3.0 are presented.